SE-TAN DHA- ferrous fumarate and polysaccharide iron capsule, gelatin coated 
Cameron Pharmaceuticals

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Se-Tan DHA

Ferrous Fumarate/Polysaccharide Iron Complex Vitamin Mineral Complex Prenatal Capsules With DHA

Rx Only

DESCRIPTION: Each purple liquid filled soft capsule contains:

Ferrous Fumarate (Elemental Iron) 15 mg
Polysaccharide Iron Complex (Elemental Iron)
(Equivalent to about 30 mg of elemental iron)
15 mg
Vitamin C (Sodium Ascorbate) 20 mg
Folic Acid 1 mg
Vitamin B6 (Pyridoxine HCI) 25 mg
Omega-3 Fatty Acids
(Derived from at least 450 mg Fish Oil)
310.1 mg
Docosahexaenoic Acid (DHA) 215.12 mg
Eicosapentaenoic Acid (EPA) 53.46 mg

Inactive Ingredients:

Gelatin, Mixed tocopherols, Titanium Dioxide, FD&C Blue #1, FD&C Red #3.

INDICATIONS:

Se-Tan DHA is a prescription prenatal vitamin-mineral preparation containing omega-3 fatty acid supplements designed to supply nutritional supplementation for women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Se-Tan DHA may also be used to improve the nutritional status of women before conception.

CONTRAINDICATIONS:

Se-Tan DHA is contraindicated in patients with known hypersensitivity to any of its ingredients, including fish or fish oil; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

WARNING: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six. Keep this and all drugs out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids from fish oils per day may have potential antithrombotic effects, including an increased bleeding time and INR (international normalized ratio). DHA should be avoided in patients with inherited or acquired bleeding diatheses, including those taking anticoagulants.

Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.

PRECAUTIONS:

General: Folic acid in doses above 0.1 mg -0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.

Pediatric Use: Safety and effectiveness of this product have not been established in pediatric patients.

Geriatric Use: No clinical studies have been performed in patients age 65 and over to determine whether older persons respond differently from younger persons. Dosage should always begin at the low end of the dosage scale and should consider that elderly persons may have decreased hepatic, renal, or cardiac function and or concomitant diseases.

Adverse Reactions:

Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.

Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Se-Tan DHA after meals may control occasional G.I. disturbances. Se-Tan DHA is best absorbed when taken at bedtime.

OVERDOSE:

Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300-mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Se-Tan DHA should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of the reach of children.

Treatment: For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.

DOSAGE AND ADMINISTRATION:

Adults (persons over 12 years of age), one (1) capsule daily, orally, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.

HOW SUPPLIED:

Se-Tan DHA are purple, oblong, liquid filled soft capsules imprinted "T513". Child resistant bottles of 90 capsules.
NDC 42494-119-90.
Dispense in a tight, light resistant container as defined in the USP/NF with a child resistant closure.

Storage:

Store at controlled room temperature 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Keep in a cool, dry place.

KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN

Rx Only.

RESERVED FOR PROFESSIONAL RECOMMENDATION.

Manufactured for:
CAMERONTM PHARMACEUTICALS
Manasquan, NJ 08736
1-800-510-3401

MADE IN CANADA         REV. MAR-2012

CAMERON PHARMACEUTICALS

PRINCIPAL DISPLAY PANEL:

NDC 42494-119-90

Se-Tan-DHA

Ferrous Fumarate/Polysaccharide Iron Complex Vitamin
Mineral Complex Prenatal Capsules With DHA

90 Capsules

Rx Only

CAMERON PHARMACEUTICALS

Container Label
SE-TAN DHA 
ferrous fumarate and polysaccharide iron capsule, gelatin coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42494-119
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION15 mg
IRON DEXTRAN (UNII: 95HR524N2M) (FERRIC CATION - UNII:91O4LML611) FERRIC CATION15 mg
SODIUM ASCORBATE (UNII: S033EH8359) (ASCORBIC ACID - UNII:PQ6CK8PD0R) SODIUM ASCORBATE20 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE25 mg
OMEGA-3 FATTY ACIDS (UNII: 71M78END5S) (OMEGA-3 FATTY ACIDS - UNII:71M78END5S) OMEGA-3 FATTY ACIDS310.1 mg
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT215.12 mg
ICOSAPENT (UNII: AAN7QOV9EA) (ICOSAPENT - UNII:AAN7QOV9EA) ICOSAPENT53.46 mg
Inactive Ingredients
Ingredient NameStrength
GELATIN (UNII: 2G86QN327L)  
TOCOPHEROL (UNII: R0ZB2556P8)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
FD&C RED NO. 3 (UNII: PN2ZH5LOQY)  
Product Characteristics
ColorPURPLEScoreno score
ShapeCAPSULESize23mm
FlavorImprint Code T513
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42494-119-9090 in 1 BOTTLE; Type 0: Not a Combination Product10/01/200907/26/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/01/200907/26/2017
Labeler - Cameron Pharmaceuticals (078371442)
Establishment
NameAddressID/FEIBusiness Operations
VIVA253288898MANUFACTURE(42494-119)
Establishment
NameAddressID/FEIBusiness Operations
Rainbow Gold800695152REPACK(42494-119)

Revised: 8/2017
 
Cameron Pharmaceuticals